Company profile for Pharming

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Pharming is a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs. We are committed to transforming the future for our patients. We develop innovative products for the treatment of unmet medical needs. Pharming’s lead product, RUCONEST® (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute her...
Pharming is a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs. We are committed to transforming the future for our patients. We develop innovative products for the treatment of unmet medical needs. Pharming’s lead product, RUCONEST® (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute hereditary angioedema (“HAE”) attacks in patients in Europe, the US, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Netherlands
Address
Address
Pharming Group NV Vondellaan 47 2332 AA Leiden
Telephone
Telephone
+31 (0)71 5247 400
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/30/3177070/0/en/Pharming-Group-to-participate-in-Fireside-Chat-at-Jefferies-Global-Healthcare-Conference-in-London.html

GLOBENEWSWIRE
30 Oct 2025

https://www.globenewswire.com/news-release/2025/10/23/3171694/0/en/Pharming-Group-to-report-third-quarter-2025-financial-results-and-provide-business-update-on-November-6.html

GLOBENEWSWIRE
23 Oct 2025

https://www.globenewswire.com/news-release/2025/10/20/3169083/0/en/Pharming-Group-announces-presentations-at-2025-ACAAI-Annual-Scientific-Meeting-showcasing-new-data-across-rare-disease-portfolio.html

GLOBENEWSWIRE
20 Oct 2025

https://www.globenewswire.com/news-release/2025/10/06/3161919/0/en/Pharming-Group-provides-update-on-previously-announced-G-A-expense-reduction-plan.html

GLOBENEWSWIRE
06 Oct 2025

https://www.globenewswire.com/news-release/2025/10/01/3159182/0/en/Pharming-Group-announces-U-S-FDA-acceptance-and-Priority-Review-of-supplemental-New-Drug-Application-for-leniolisib-in-children-with-APDS-aged-4-to-11-years.html

GLOBENEWSWIRE
01 Oct 2025

https://www.globenewswire.com/news-release/2025/09/10/3147468/0/en/Pharming-Group-promoted-to-the-Euronext-AMX-index.html

GLOBENEWSWIRE
10 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty